Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer Patients

• Status: Unknown status
• Trial end date: 2012-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

This is a two-year double blind, placebo-controlled, and randomized clinical trial, which is aimed to evaluate the effects of Chinese medical treatment on leucopenia after chemotherapy in breast cancer patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: China Medical University Hospital
• Collaborator: Department of Health, Executive Yuan, R.O.C. (Taiwan)

Criteria

Inclusion Criteria:

• Newly diagnosed breast cancer patient (age ≧18, Stage I, II, IIIa)

• Receive chemotherapy after operation

Exclusion Criteria:

• Before receiving operation and chemotherapy, the patient already have other chronic diseases.

• Already have hematological malignancy and other lethal disease.

• Pregnant.

• Have severe psychological diseases.